Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
has a patent on EPO variants and is a member of the SINAPPS2 TSC
L., Ma, S
Preclinical models published in Obesity Research demonstrated that AOD-9604 administration increased lipolysis by 47% within 90 minutes of subcutaneous injection, with peak plasma concentrations occurring at 120 minutes post-dose
Toxic chemical release inventory
1) Decipher cell type-specific ferroptosis regulatory networks: Use integrated single-cell multi-omics (scRNA-seq, Single-cell Assay for Transposase-Accessible Chromatin with High-throughput Sequencing (scATAC-seq), and single-cell metabolomics) to map ferroptosis-related gene expression, chromatin accessibility, and metabolite profiles across renal cell types in health and disease
Cras fermentum nunc quis tempor iaculis
US$ 24.63
US$ 23.44
US$ 28.55
US$ 27.75
US$ 25.25
